Abstract
Recently, co-delivery of siRNA and anticancer drugs has drawn much attention in the treatment of drug-resistant cancers. Drug resistance is exhibited by cancer cells, which limits the efficacy of chemotherapy. When siRNA and anticancer drugs are delivered into cancer cells simultaneously, the siRNA is expected to silence the genes related to drug resistance, decreasing the drug efflux pumps and activating the cell’s apoptosis pathways. In a timeframe following the release of siRNA, the accumulation of the co-delivered anti-cancer drug inside of the cancer cells will increase, resulting in promoted chemotherapeutic effects. Several classes of nanocarriers have been designed based on polymers for co-delivery, including surface-modified polymer nanoparticles (NPs), polymer micelles, dendrimers, polymer nanocapsules, polymer-modified liposomes, and polymer-modified silica and gold NPs. Compared with separate delivery, co-delivery showed significant advantages in the treatment of drug-resistant cancers. This review focuses on polymers in the co-delivery of siRNA and anticancer drugs, and summarizes key advances in the recent several years.
Similar content being viewed by others
Abbreviations
- ABC:
-
ATP-binding cassette
- Bcl-2:
-
B-cell lymphoma 2
- BCRP:
-
Breast cancer resistance protein
- CPLA:
-
Cationic polylactide
- CPT:
-
Camptothecin
- CS:
-
Chitosan
- CSC:
-
Cancer stem cell
- CyD:
-
Cyclodextrin
- DDAB:
-
Dimethyldioctadecyl ammonium bromide
- DEA:
-
Diethyldiamine
- DOC:
-
Docetaxel
- DOPE:
-
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine
- DOX:
-
Doxorubicin
- DSPE:
-
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine
- DTT:
-
14-Dithiothreitol
- EpCAM:
-
Epithelial cell adhesion molecule
- FA:
-
Folic acid
- Fol:
-
Folate
- Gem:
-
Gemcitabine
- HepG2:
-
Hepatic G2 cells
- HIF1 α:
-
Hypoxia-inducible factor 1α
- HNP:
-
Hybrid nanoparticle
- HPG:
-
Hyperbranched polyglycerol
- HZ:
-
Hydrazone
- LDL:
-
Low-density lipoprotein
- LENP:
-
Lipid/ε-polylysine-coated nanoparticle
- LND:
-
Lonidamine
- LNP:
-
Lipid nanoparticle
- MDR:
-
Multidrug resistance
- MNP:
-
Magnetic nanoparticle
- MRP1:
-
MDR-associated protein 1
- N/P:
-
Nitrogenphosphate
- NP:
-
Nanoparticle
- NCP:
-
Nanoscale coordination polymer
- NIR:
-
Near-infrared
- NSC:
-
N-succinyl chitosan
- OCN:
-
One-component nanomedicine
- PAA:
-
Poly(acrylic acid)
- PAMAM:
-
Poly(amidoamine)
- PBLA:
-
Poly(β-benzyl l-aspartate)
- PCB:
-
Polycarboxybetaine
- PCL:
-
Polycaprolactone
- PDHA:
-
Poly(dihydroxy acetone)
- PDMA:
-
Poly(dimethyl acrylamide)
- PDMAEMA:
-
Poly(dimethylaminoethyl methacrylate)
- PDPA:
-
Poly[(2-diisopropylamino)ethyl methacrylate]
- PE:
-
Polyethylene
- PEG or PEO:
-
Poly(ethylene glycol)
- PEI:
-
Polyethyleneimine
- PGAH:
-
Poly(l-glutamic acid γ-hydrazide)
- P-gp:
-
P-glycoprotein
- PHD:
-
PEI-HZ-DOX
- PKB:
-
Protein kinase B
- PLGA:
-
Poly(lactic-co-glycolic acid)
- PLL:
-
Poly-l-lysine
- PLLD:
-
Poly(l-lysine) dendrimer
- PLLeu:
-
Poly-l-leucine
- PNC:
-
Polymer nanocapsules
- PPF:
-
PEI-PEG-Folate
- PTX:
-
Paclitaxel
- RNAi:
-
RNA interference
- siRNA:
-
Short interfering RNA
- SSNP:
-
Supramolecular self-assembled NP
- TEA:
-
Triethanolamine
- TNF-α:
-
Tumor necrosis factor-α
- VEGF:
-
Vascular endothelial growth factor
References
Siegel RL, Miller KD, Jemal A (2016) CA CA Cancer J Clin 66:7
Qiu LY, Bae YH (2006) Pharm Res 23:1
Halama A, Kuliński M, Librowski T, Lochyński S (2009) Pharmacol Rep 61:993
Satchi-Fainaro R, Duncan R, Barnes CM (2006) In: Satchi-Fainaro R, Duncan R (eds) Polymer therapeutics II. Springer, Berlin, p 1
De Smedt SC, Demeester J, Hennink WE (2000) Pharm Res 17:113
Pack DW, Hoffman AS, Pun S, Stayton PS (2005) Nat Rev Drug Discov 4:581
Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Cancers 6:1769
Tsouris V, Joo MK, Kim SH, Kwon IC, Won Y-Y (2014) Biotechnol Adv 32:1037
Khan M, Ong ZY, Wiradharma N, Attia ABE, Yang Y-Y (2012) Adv Healthc Mater 1:373
Creixell M, Peppas NA (2012) Nano Today 7:367
Zhao J, Feng S-S (2015) Nanomed (London UK) 10:2199
Yang Z, Gao D, Cao Z, Zhang C, Cheng D, Liu J, Shuai X (2015) Biomater Sci 3:1035
Kanasty R, Dorkin JR, Vegas A, Anderson D (2013) Nat Mater 12:967
Kesharwani P, Gajbhiye V, Jain NK (2012) Biomaterials 33:7138
Oh Y-K, Park TG (2009) Adv Drug Deliv Rev 61:850
Jeong JH, Park TG, Kim SH (2011) Pharm Res 28:2072
Petersen H, Fechner PM, Martin AL, Kunath K, Stolnik S, Roberts CJ, Fischer D, Davies MC, Kissel T (2002) Bioconjugate Chem 13:845
Miteva M, Kirkbride KC, Kilchrist KV, Werfel TA, Li H, Nelson CE, Gupta MK, Giorgio TD, Duvall CL (2015) Biomaterials 38:97
Gallon E, Matini T, Sasso L, Mantovani G, Arminan de Benito A, Sanchis J, Caliceti P, Alexander C, Vicent MJ, Salmaso S (2015) Biomacromolecules 16:1924
Xu X, Wu J, Liu Y, Yu M, Zhao L, Zhu X, Bhasin S, Li Q, Ha E, Shi J, Farokhzad OC (2016) Angew Chem Int Ed 55:7091
Park TG, Jeong JH, Kim SW (2006) Adv Drug Deliv Rev 58:467
Putnam D, Langer R (1999) Macromolecules 32:3658
Chen C-K, Law W-C, Aalinkeel R, Nair B, Kopwitthaya A, Mahajan SD, Reynolds JL, Zou J, Schwartz SA, Prasad PN, Cheng C (2012) Adv Healthc Mater 1:751
Aalinkeel R, Nair B, Chen C-K, Mahajan SD, Reynolds JL, Zhang H, Sun H, Sykes DE, Chadha KC, Turowski SG, Bothwell KD, Seshadri M, Cheng C, Schwartz SA (2016) Immunology 148:387
Yin L, Zheng N, Cheng J (2016) In: Shum K, Rossi J (eds) siRNA delivery methods: methods and protocols. Springer, New York, p 37
He H, Zheng N, Song Z, Kim KH, Yao C, Zhang R, Zhang C, Huang Y, Uckun FM, Cheng J, Zhang Y, Yin L (2016) ACS Nano 10:1859
Yin L, Song Z, Qu Q, Kim KH, Zheng N, Yao C, Chaudhury I, Tang H, Gabrielson NP, Uckun FM, Cheng J (2013) Angew Chem Int Ed 52:5757
Zheng N, Song Z, Liu Y, Zhang R, Zhang R, Yao C, Uckun FM, Yin L, Cheng J (2015) J Control Release 205:231
Whitehead KA, Dorkin JR, Vegas AJ, Chang PH, Veiseh O, Matthews J, Fenton OS, Zhang Y, Olejnik KT, Yesilyurt V, Chen D, Barros S, Klebanov B, Novobrantseva T, Langer R, Anderson DG (2014) Nat Commun 5:4277
Lee SJ, Yook S, Yhee JY, Yoon HY, Kim M-G, Ku SH, Kim SH, Park JH, Jeong JH, Kwon IC, Lee S, Lee H, Kim K (2015) J Control Release 220:631
Duncan R (2003) Nat Rev Drug Discov 2:347
Elsabahy M, Wooley KL (2012) Chem Soc Rev 41:2545
Tong R, Cheng J (2007) Polym Rev 47:345
Su H, Koo JM, Cui H (2015) J Control Release 219:383
Ma W, Cheetham AG, Cui H (2016) Nano Today 11:13
Duncan R (2006) Nat Rev Cancer 6:688
Khandare J, Minko T (2006) Prog Polym Sci 31:359
Yu Y, Chen C-K, Law W-C, Sun H, Prasad PN, Cheng C (2015) Polym Chem 6:953
Zhang F, Zhang S, Pollack SF, Li R, Gonzalez AM, Fan J, Zou J, Leininger SE, Pavía-Sanders A, Johnson R, Nelson LD, Raymond JE, Elsabahy M, Hughes DMP, Lenox MW, Gustafson TP, Wooley KL (2015) J Am Chem Soc 137:2056
Veronese FM, Pasut G (2005) Drug Discov Today 10:1451
Mura S, Nicolas J, Couvreur P (2013) Nat Mater 12:991
Chen W, Du J (2013) Sci Rep 3:2162
Bae YH, Park K (2011) J Control Release 153:198
Stella B, Arpicco S, Peracchia MT, Desmaële D, Hoebeke J, Renoir M, D’Angelo J, Cattel L, Couvreur P (2000) J Pharm Sci 89:1452
Brannon-Peppas L, Blanchette JO (2012) Adv Drug Deliv Rev 64(Supplement):206
Aina OH, Sroka TC, Chen M-L, Lam KS (2002) Peptide Sci 66:184
Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M (2008) Trends Mol Med 14:450
Borst P (1991) Acta Oncol 30:87
Gottesman MM (2002) Annu Rev Med 53:615
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Nat Rev Cancer 13:714
Zahreddine H, Borden K (2013) Front Pharmacol 4:28
Liscovitch M, Lavie Y (2002) IDrugs 5:349
Ozben T (2006) FEBS Lett 580:2903
Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Nature 348:334
Fesik SW (2005) Nat Rev Cancer 5:876
Igney FH, Krammer PH (2002) Nat Rev Cancer 2:277
Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Nat Rev Drug Discov 5:219
Wu Q, Yang Z, Nie Y, Shi Y, Fan D (2014) Cancer Lett 347:159
Kerr JFR, Winterford CM, Harmon BV (1994) Cancer 73:2013
Bertrand J-R, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C (2002) Biochem Biophys Res Commun 296:1000
Su W-P, Cheng F-Y, Shieh D-B, Yeh C-S, Su W-C (2012) Int J Nanomed 7:4269
Babu A, Wang Q, Muralidharan R, Shanker M, Munshi A, Ramesh R (2014) Mol Pharm 11:2720
Zhao X, Li F, Li Y, Wang H, Ren H, Chen J, Nie G, Hao J (2015) Biomaterials 46:13
Liu H, Li Y, Mozhi A, Zhang L, Liu Y, Xu X, Xing J, Liang X, Ma G, Yang J, Zhang X (2014) Biomaterials 35:6519
He C, Liu D, Lin W (2015) Biomaterials 36:124
He C, Poon C, Chan C, Yamada SD, Lin W (2016) J Am Chem Soc 138:6010
Cao N, Cheng D, Zou S, Ai H, Gao J, Shuai X (2011) Biomaterials 32:2222
Zou S, Cao N, Cheng D, Zheng R, Wang J, Zhu K, Shuai X (2012) Int J Nanomedicine 7:3823
Qian J, Xu M, Suo A, Xu W, Liu T, Liu X, Yao Y, Wang H (2015) Acta Biomater 15:102
Xu M, Qian J, Suo A, Liu T, Liu X, Wang H (2015) Polym Chem 6:2445
Shen J, Wang Q, Hu Q, Li Y, Tang G, Chu PK (2014) Biomaterials 35:8621
Xiong X-B, Lavasanifar A (2011) ACS Nano 5:5202
Amjad MW, Amin MCIM, Katas H, Butt AM, Kesharwani P, Iyer AK (2015) Mol Pharm 12:4247
Dong D-W, Xiang B, Gao W, Yang Z-Z, Li J-Q, Qi X-R (2013) Biomaterials 34:4849
Dong D, Gao W, Liu Y, Qi X-R (2015) Cancer Lett 359:178
Zheng C, Zheng M, Gong P, Deng J, Yi H, Zhang P, Zhang Y, Liu P, Ma Y, Cai L (2013) Biomaterials 34:3431
Zhu C, Jung S, Luo S, Meng F, Zhu X, Park TG, Zhong Z (2010) Biomaterials 31:2408
Yu H, Xu Z, Chen X, Xu L, Yin Q, Zhang Z, Li Y (2014) Macromol Biosci 14:100
Yang S-D, Zhu W-J, Zhu Q-L, Chen W-L, Ren Z-X, Li F, Yuan Z-Q, Li J-Z, Liu Y, Zhou X-F, Liu C, Zhang X-N (2016) J Biomed Mater Res B. doi:10.1002/jbm.b.33636 (Ahead of Print)
Tang S, Yin Q, Su J, Sun H, Meng Q, Chen Y, Chen L, Huang Y, Gu W, Xu M, Yu H, Zhang Z, Li Y (2015) Biomaterials 48:1
Jones SK, Lizzio V, Merkel OM (2016) Biomacromolecules 17:76
Liu T, Xue W, Ke B, Xie M-Q, Ma D (2014) Biomaterials 35:3865
Kala S, Mak ASC, Liu X, Posocco P, Pricl S, Peng L, Wong AST (2014) J Med Chem 57:2634
Biswas S, Deshpande PP, Navarro G, Dodwadkar NS, Torchilin VP (2013) Biomaterials 34:1289
Sherwani MA, Tufail S, Khan AA, Owais M (2015) RSC Adv 5:39512
Zhou X, Zheng Q, Wang C, Xu J, Wu J-P, Kirk TB, Ma D, Xue W (2016) ACS Appl Mater Interfaces 8:12609
Chen C-K, Law W-C, Aalinkeel R, Yu Y, Nair B, Wu J, Mahajan S, Reynolds JL, Li Y, Lai CK, Tzanakakis ES, Schwartz SA, Prasad PN, Cheng C (2014) Nanoscale 6:1567
Chen J, Liu Q, Xiao J, Du J (2015) Biomacromolecules 16:1695
Li Z, Li J, Huang J, Zhang J, Cheng D, Shuai X (2015) Macromol Biosci 15:1497
Liu C, Zhao G, Liu J, Ma N, Chivukula P, Perelman L, Okada K, Chen Z, Gough D, Yu L (2009) J Control Release 140:277
Kazunori K, Glenn SK, Masayuki Y, Teruo O, Yasuhisa S (1993) J Control Release 24:119
Kwon GS, Okano T (1996) Adv Drug Deliv Rev 21:107
Miyata K, Christie RJ, Kataoka K (2011) React Funct Polym 71:227
Hao S, Yan Y, Ren X, Xu Y, Chen L, Zhang H (2015) Biotechnol Bioprocess Eng 20:550
Kesharwani P, Jain K, Jain NK (2014) Prog Polym Sci 39:268
Yang J, Zhang Q, Chang H, Cheng Y (2015) Chem Rev 115:5274
Sun H, Chen C-K, Cui H, Cheng C (2016) Polym Int 65:351
Mora-Huertas CE, Fessi H, Elaissari A (2010) Int J Pharm 385:113
Hu S-H, Chen S-Y, Gao X (2012) ACS Nano 6:2558
Li Y, Liu R, Yang J, Ma G, Zhang Z, Zhang X (2014) Biomaterials 35:9731
Yin T, Wang P, Li J, Wang Y, Zheng B, Zheng R, Cheng D, Shuai X (2014) Biomaterials 35:5932
Meng H, Liong M, Xia T, Li Z, Ji Z, Zink JI, Nel AE (2010) ACS Nano 4:4539
Meng H, Mai WX, Zhang H, Xue M, Xia T, Lin S, Wang X, Zhao Y, Ji Z, Zink JI, Nel AE (2013) ACS Nano 7:994
Chen AM, Zhang M, Wei D, Stueber D, Taratula O, Minko T, He H (2009) Small 5:2673
Ma X, Zhao Y, Ng KW, Zhao Y (2013) Chem Eur J 19:15593
Xiao Y, Jaskula-Sztul R, Javadi A, Xu W, Eide J, Dammalapati A, Kunnimalaiyaan M, Chen H, Gong S (2012) Nanoscale 4:7185
Yin F, Yang C, Hu R, Yong K-T, Wang Q, Lu F, Zeng S, Lin G, Tian J, Hu S, Lan RF, Yoon HS, Wang K (2015) Theranostics 5:818
Zhang P, Wang C, Zhao J, Xiao A, Shen Q, Li L, Li J, Zhang J, Min Q, Chen J, Chen H-Y, Zhu J-J (2016) ACS Nano 10:3637
Conde J, Oliva N, Zhang Y, Artzi N (2016) Nat Mater 15:1128
Wang H, Zhao P, Su W, Wang S, Liao Z, Niu R, Chang J (2010) Biomaterials 31:8741
Saad M, Garbuzenko OB, Minko T (2008) Nanomedicine 3:761
Anglin EJ, Cheng L, Freeman WR, Sailor MJ (2008) Adv Drug Deliv Rev 60:1266
Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Adv Drug Deliv Rev 60:1307
Mendonça LS, Moreira JN, de Lima MCP, Simões S (2010) Biotechnol Bioeng 107:884
Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, Chan WCW (2016) Nat Rev Mater 1:16014
Hu C, Fang R, Luk B, Zhang L (2014) Nanoscale 6:65
Bertrand N, Leroux JC (2012) J Control Release 161:152
Acknowledgements
The authors thank the US National Science Foundation for financial support (DMR-1206715, DMR-1609914). The authors also acknowledge the collaborations with all the coworkers.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection “Polymeric Gene Delivery Systems”; edited by Yiyun Cheng.
Rights and permissions
About this article
Cite this article
Sun, H., Yarovoy, I., Capeling, M. et al. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers. Top Curr Chem (Z) 375, 24 (2017). https://doi.org/10.1007/s41061-017-0113-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s41061-017-0113-z